Welcome!
公司新闻
联系我们
  全国免费咨询电话:
400-048-9198
公司新闻
Position:Home/公司新闻

Assist force pharmaceutical to deal

发布时间:2014-07-29

Assist force pharmaceutical acquisition of Everest in qinghai cordyceps pharmaceutical co., LTD. (hereinafter referred to as mount Everest in qinghai) wave. On July 28, in the afternoon, "the Chinese caterpillar fungus fungus fermentation production method" patent holders xiao-ning zhou told the Beijing news reporter, respects has entrusted a lawyer to assist force pharmaceutical, ask for "careful consideration" in qinghai's Everest equity investment.

Pharmaceutical industry announced on July 7, with force, to 150 million acquisition of Everest in qinghai cordyceps pharmaceutical co., LTD. 51% stake. Because there are serious the acquisition target company, patent infringement disputes, with force pharmaceutical sparked heated debate the purchase for the moment.

On July 28, in the afternoon, "the Chinese cordyceps sinensis fungal fermentation production method" patent to our reporter revealed that the current holder xiao-ning zhou had already sent a letter to assist force pharmaceutical industry, the content is required with force pharmaceutical "careful consideration in qinghai's Everest equity investment." Xiao-ning zhou also said that if the "force in pharmaceutical industry of qinghai cordyceps Everest pharmaceutical co., LTD. Completing the acquisition and use the relevant patent production, oneself will not rule out the zc force pharmaceutical industry as the defendant.

Learned, with force the main purpose of the pharmaceutical industry to buy is the "best". Everest Everest in qinghai cordyceps parent company pharmaceutical in qinghai in July 21, 2008, the state food and drug administration about the production approval of "hundreds of land".

It is understood that "hundreds of land" and "Chinese cordyceps sinensis fungal fermentation production method" patent is closely linked. The patent inventor and the original holder (shareholder) at the same time as mount Everest in qinghai cordyceps pharmaceutical Shen Naying professor, told reporters that the patent "never belong to the Everest in qinghai cordyceps pharmaceutical industry and its chairman maike", qinghai Everest power to "hundreds of land" based on the patent production sales.

This is Mr Force pharmaceutical industry for the second time this month because of to buy "qinghai Everest's" and received the lawyer letter. Respects before Shen Naying entrust a lawyer to assist force pharmaceutical industry, according to Everest cordyceps lawsuit, to assist force pharmaceutical related to buy matters.

Reporter xiao-ning zhou to send the lawyer letter to assist with force pharmaceutical pharmaceutical equities and verification, but by the time, did not get reply.

All rights reserved:中海知识产权 苏ICP备15009363-2号
TEL:0516-85959279  EMAIL:ipzhonghai@163.com
ADD:Building A1,NO.90 North Yellow River Rd..,Xuzhou
Online
hotline
400-048-9198
Weixin

苏公网安备 32030202000283号